Holders over time
- LINE
- EQIX
| Quarter | LINE | EQIX |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 19 holders, $8.2bn |
| Q4 2020 | none listed holders, n.a. | 21 holders, $8.2bn |
| Q1 2021 | none listed holders, n.a. | 19 holders, $7.5bn |
| Q2 2021 | none listed holders, n.a. | 17 holders, $7.9bn |
| Q3 2021 | none listed holders, n.a. | 15 holders, $7.0bn |
| Q4 2021 | none listed holders, n.a. | 18 holders, $6.0bn |
| Q1 2022 | none listed holders, n.a. | 18 holders, $6.0bn |
| Q2 2022 | none listed holders, n.a. | 23 holders, $5.7bn |
| Q3 2022 | none listed holders, n.a. | 20 holders, $4.8bn |
| Q4 2022 | none listed holders, n.a. | 15 holders, $5.1bn |
| Q1 2023 | none listed holders, n.a. | 17 holders, $5.3bn |
| Q2 2023 | none listed holders, n.a. | 20 holders, $6.5bn |
| Q3 2023 | none listed holders, n.a. | 16 holders, $6.2bn |
| Q4 2023 | none listed holders, n.a. | 19 holders, $6.6bn |
| Q1 2024 | none listed holders, n.a. | 27 holders, $7.6bn |
| Q2 2024 | none listed holders, n.a. | 21 holders, $8.1bn |
| Q3 2024 | 16 holders, $1.5bn | 26 holders, $9.6bn |
| Q4 2024 | 12 holders, $1.1bn | 28 holders, $10.3bn |
| Q1 2025 | 9 holders, $1.3bn | 31 holders, $8.7bn |
| Q2 2025 | 11 holders, $1.0bn | 30 holders, $7.3bn |
| Q3 2025 | 7 holders, $646m | 28 holders, $7.0bn |
| Q4 2025 | 6 holders, $481m | 26 holders, $8.2bn |
| Q1 2026 | 4 holders, $341m | 31 holders, $11.5bn |
| Q2 2026 | 4 holders, $513m | 31 holders, $12.6bn |
Lineage Cell Theraputics In
- Holders
- 9
- Reported value
- $1.3bn
- Buyers
- 6
- Sellers
- 3
Breadth +3 among 95 comparable managers.
Equinix Inc
- Holders
- 31
- Reported value
- $8.7bn
- Buyers
- 21
- Sellers
- 10
Breadth +11 among 95 comparable managers.
Who holds both, Q1 2025
Both (4)
Artisan Partners LP, Capital Research Global Investors, Janus Henderson Group Ltd, T. Rowe Price Associates Inc
Only LINE (5)
Baillie Gifford & Co, Capital World Investors, D1 Capital Partners LP, Holocene Advisors LP, Woodline Partners LP
Only EQIX (27)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Elliott Investment Management LP, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Freestone Grove Partners LP, Invesco Ltd, Man Group PLC, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, and 2 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.